Enveric Biosciences
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -37 | -39 | -40 | -39 |
EBITDA | -1,595 | -2,154 | -1,833 | -2,479 |
EBIT | -1,633 | -2,193 | -1,873 | -2,519 |
Net Income | -1,633 | -2,194 | -1,873 | -2,519 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -2,256 | -1,784 | -2,074 | -1,890 |
Cash | 4,908 | 4,677 | 3,757 | 2,849 |
Basic Shares | 1,510 | 1,061 | 313 | 216 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -200 | -337 | -408 | -435 |
EBITDA | -8,571 | -9,228 | -16,854 | -19,516 |
EBIT | -8,771 | -9,566 | -17,262 | -19,952 |
Net Income | -12,131 | -9,574 | -17 | -18,504 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -8,141 | -7,726 | -14,099 | -17,730 |
Cash | 4,677 | 2,241 | 2,287 | 17,723 |
Basic Shares | 334 | 41 | 11 | 8 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$1.08 |
2025-12-31 | -$3.80 |
2025-09-30 | -$10.81 |
2025-06-30 | -$11.65 |